| Literature DB >> 31316480 |
Dengfeng Qi1, Liangping Zou1, Dengbo Zhou1, Yufeng Chen1, Zhufen Gao1, Renjun Feng1, Miaoyi Zhang1, Kan Li1, Jianghui Xie1, Wei Wang1.
Abstract
Actinobacteria are important producers of bioactive compounds. Extreme ecosystems cause evolution of novel secondary metabolic pathways of Actinobacteria and increase the possible discovery of new biological functions of bioactive compounds. Here, we isolated 65 Actinobacteria from rhizosphere soil samples of Opuntia stricta. An Actinobacteria strain (named SCA3-4) was screened against Fusarium oxysporum f. sp. cubense Tropical Race 4 (Foc TR4, ATCC 76255). The strain produced pink-white aerial mycelia and brown substrate mycelium on Gause No. 1 agar. Biverticillate chains of cylindrical spores were observed by scanning electron microscopy (SEM). Based on alignment of 16S rRNA sequences, a constructed phylogenetic tree showed that strain SCA3-4 shared a 99.54% similarity with Streptomyces lilacinus NRRL B-1968T. The morphological, biochemical, physiological, and molecular characteristics further indicated that strain SCA3-4 belongs to the Streptomyces sp. It can grow well on medium with the following antibiotics chloramphenicol, streptomycin, penicillin-G, gentamicin, erythromycin, nystatin or neomycin sulfate. The polymerase chain reaction (PCR) amplification of types I and II polyketide synthase genes (PKS-I and PKS-II) suggested its bioactive potential. Under treatment with 100 μg/ml of ethyl acetate extracts isolated from Streptomyces sp. SCA3-4, growth of Foc TR4 was inhibited and cell membrane was destroyed. Crude extracts also showed a broad-spectrum antifungal activity against 13 phytopathogenic fungi including Foc TR4 and displayed the lowest minimum inhibitory concentration (MIC) (0.781 μg/ml) against Colletotrichum fragariae (ATCC 58718). A total of 21 different compounds identified by gas chromatography-mass spectrometry (GC-MS) were composed of phenolic compound, pyrrolizidine, hydrocarbons, esters, and acids. Besides the known active compounds, Streptomyces sp. SCA3-4 possesses antimicrobial or other biological activities. Further attention will be paid on other compounds with no functional annotation, aiming at the discovery of new bioactive substances.Entities:
Keywords: Actinobacteria; GC-MS; Streptomyces lilacinus; antifungal activity; banana Fusarium wilt; biosynthetic genes
Year: 2019 PMID: 31316480 PMCID: PMC6609889 DOI: 10.3389/fmicb.2019.01390
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Inhibition of strain SCA3-4 on the mycelium growth of Foc TR4. Control, plate inoculated only with Foc TR4; Treatment, plate inoculated with Foc TR4 and strain SCA3-4.
Cultural characteristics of strain SCA3-4.
| Trytone-yeast extract agar (ISP2 or YE) | Pink white | Brown | Brown | +++ |
| Oatmeal agar (ISP3) | Light–pink | Light–yellow | Brown | +++ |
| Inorganic salts–starch agar (ISP4) | Pink white | Brown | None | +++ |
| Glycerol–asparagine agar (ISP5) | Beige | Light–yellow | None | ++ |
| Peptone–yeast extract iron agar (ISP6) | Light–purple | Red–brown | Red | ++ |
| Tyrosine agar (ISP7) | Pink–gray | Brown | None | +++ |
| Gause No. 1 agar | Pink–white | Brown | None | +++ |
| PDA | Pink white | Brown | Brown | +++ |
FIGURE 2Morphologic characteristics of mycelium (A) as well as spore chain and spore (B) of strain SCA3-4.
Morphological, physiological, and biochemical characteristics of strain SCA3-4.
| Aerial mycelium color | Pink–white |
| Substrate mycelium color | Brown |
| Spore chain morphology | Biverticillate, straight, and short |
| Spore surface | Smooth |
| Spore shape | Cylindrical |
| Temperature range for growth (°C) | 21–44 (optimum 28–43) |
| pH range for growth | 5–8 (optimum 7) |
| NaCl tolerance for growth (%) | 0–5 |
| Urease production | − |
| Tween 20 | + |
| Tween 80 | + |
| Degradation of cellulose | − |
| Melanoid pigment | − |
| Tyrosinase production | + |
| Starch hydrolysis | − |
| H2S production | − |
| Gelatin liquefaction | + |
| Nitrate reduction | + |
Nutrition Utilization and Antibiotic characteristics of strain SCA3-4.
| D-xylose | – |
| D-mannitol | – |
| L-arabinose | + |
| Soluble starch | + |
| Melezitose | – |
| D-glucose | + |
| Sucrose | + |
| L-Rhamnose | + |
| Maltose | + |
| D-raffinose | + |
| D-galactose | – |
| Melibiose | + |
| D-ribose | + |
| Inositol | + |
| Salicin | + |
| Trehalose | – |
| D-fructose | – |
| D-cellobiose | + |
| D-sorbitol | – |
| Xylan | + |
| L-phenylalanine | + |
| Ammonium sulfate | + |
| L-hydroxyproline | + |
| L(+)-cysteine | + |
| Histidine | + |
| Glycine | + |
| Valine | + |
| Ammonium oxalate | + |
| Ammonium acetate | – |
| Ammonium nitrate | – |
| Ammonium molybdate tetrahydrate | – |
| L-arginine | – |
| Glutamate | – |
| Ampicillin (0.5) | S |
| Chloramphenicol (1.5) | R |
| Streptomycin (0.5) | R |
| Penicillin-G (0.5) | R |
| Gentamicin (1.0) | R |
| Erythromycin (0.25) | R |
| Nystatin (5) | R |
| Tetracycline (1.5) | S |
| Neomycin sulfate (0.5) | R |
| Kanamycin sulfate (0.5) | S |
| Rifampicin (0.5) | S |
FIGURE 3Construction of phylogenetic tree based on the 16S rRNA sequences from strain SCA3-4 and other selected strains. The phylogenetic tree was constructed using the neighbor-joining method. Numbers on the branches are bootstrap values calculated from 1,000 replicates. Bar, 0.002 substitutions per nucleotide position.
Inhibitory activities of Streptomyces sp. SCA3-4 against plant pathogenic fungi.
Minimum inhibitory concentration values of crude extracts of Streptomyces sp. SCA3-4 against 13 pathogenic fungi.
| >0.781 | >12.5 | >25 | |
| >6.25 | >0.391 | >25 | |
| >25 | >50 | >25 | |
| >12.5 | > 0.391 | >25 | |
| >1.563 | >25 | >12.5 | |
| >12.5 | >0.781 | >50 | |
| >1.563 | >1.563 | >6.25 | |
| >12.5 | >3.125 | >12.5 | |
| >3.125 | >12.5 | >25 | |
| >25 | >12.5 | >0.391 | |
| >1.563 | >50 | >25 | |
| >1.563 | >6.25 | >12.5 | |
| >6.25 | >25 | >25 |
FIGURE 4Effects of the crude extracts of Streptomyces sp. SCA3-4 on spore germination of Foc TR4. Control, treatment with 10% DMSO; Treatment, treatment with the crude extracts (100 μg/ml) of Streptomyces sp. SCA3-4.
FIGURE 5Transmission electron microscopy micrographs of Foc TR4 treated with crude extracts (100 μg/ml) of Streptomyces sp. SCA3-4. (A–C) Treatment with 10% DMSO. (D–F) Treatment with the crude extracts.
FIGURE 6Chemical structures of the identified compounds from crude extracts of Streptomyces sp. SCA3-4.